In October 2016 Shore announced the sale of ClearPath Diagnostics (“ClearPath”), a leading provider of laboratory diagnostic services in the Northeastern United States, to Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH), the world’s leading healthcare diagnostics company.
EyeSouth Partners (Atlanta, GA) is an eye care services organization providing support services to eye care practices.
In August 2016 Shore announced the sale of Fast Pace, a leading provider of urgent care services throughout rural Tennessee and Kentucky, to Revelstoke Capital Partners.
In March 2020 Shore announced the sale of Florida Autism Center, a leading provider of applied behavior analysis (“ABA”) treatment services to children diagnosed with Autism Spectrum Disorder (“ASD”), to BlueSpirg Pediatrics.
Based in Baltimore, Maryland, IZI Medical Products is a leading developer, manufacturer, and provider of high quality medical consumable accessories used in radiology, radiation therapy, vertebroplasty and image guided surgery procedures.
In August 2013 Shore announced the sale of its physical therapy business, MRS, to ATI Physical Therapy. At the time of exit, MRS was the largest independent PT provider in the State of Michigan with more than 30 clinics.
In February 2021, Shore announced the sale of Navia Benefit Solutions, a third-party administrator of Flexible Spending Accounts and other tax-advantaged benefits including Commuter and Transit Benefits, Health Savings Accounts
In October 2013 Shore announced the sale of its home infusion portfolio company, Sirona, to AxelaCare Health Solutions.
In December 2017, Shore announced the sales of The Stepping Stones Group, a provider of therapeutic behavioral health services to a variety of public school districts and private learning centers.